Phase III Trial of Vinflunine Plus Best Supportive Care Compared With Best Supportive Care Alone After a Platinum-Containing Regimen in Patients With Advanced Transitional Cell Car... von BELLMUNT, Joaquim, THEODORE, Christine, DELGADO, Prançois-Michel, HURTELOUP, Patrick, MORSLI, Nassim, SALHI, Yacine, CULINE, Stéphane, VON DER MAASE, Hans, DEMKOV, Tomasz, KOMYAKOV, Boris, SENGELOV, Lisa, DAUGAARD, Gedske, CATY, Armelle, CARLES, Joan, JAGIELLO-GRUSZFELD, Agnieszka, KARYAKIN, Oleg

Volltext

Aflibercept versus placebo in combination with docetaxel and prednisone for treatment of men with metastatic castration-resistant prostate cancer (VENICE): a phase 3, double-blind... von Tannock, Ian F, Prof, Fizazi, Karim, Prof, Ivanov, Sergey, MD, Karlsson, Camilla Thellenberg, MD, Fléchon, Aude, MD, Skoneczna, Iwona, MD, Orlandi, Francisco, MD, Gravis, Gwenaelle, MD, Matveev, Vsevolod, MD, Bavbek, Sevil, Prof, Gil, Thierry, MD, Viana, Luciano, MD, Arén, Osvaldo, MD, Karyakin, Oleg, Prof, Elliott, Tony, PhD, Birtle, Alison, MD, Magherini, Emmanuelle, MD, Hatteville, Laurence, MSc, Petrylak, Daniel, Prof, Tombal, Bertrand, Prof, Rosenthal, Mark, Prof

Volltext

Addition of radium-223 to abiraterone acetate and prednisone or prednisolone in patients with castration-resistant prostate cancer and bone metastases (ERA 223): a randomised, doub... von Smith, Matthew, Parker, Chris, Saad, Fred, Miller, Kurt, Tombal, Bertrand, Ng, Quan Sing, Boegemann, Martin, Matveev, Vsevolod, Piulats, Josep Maria, Zucca, Luis Eduardo, Karyakin, Oleg, Kimura, Go, Matsubara, Nobuaki, Nahas, William Carlos, Nolè, Franco, Rosenbaum, Eli, Heidenreich, Axel, Kakehi, Yoshiyuki, Zhang, Amily, Krissel, Heiko, Teufel, Michael, Shen, Junwu, Wagner, Volker, Higano, Celestia

Volltext

PPP02 Presentation Time: 10:39 AM von Biryukov, Vitaly A., Shchukina, Elizaveta O., Ermakova, Natalia B., Sanin, Dmitry B., Lepilina, Olga G., Karyakin, Oleg B., Ivanov, Sergey A., Kaprin, Andrey D.

Volltext

PPP02 Presentation Time: 10:39 AM: Comparison of the Efficiency of Two Modes of High-Dose Rate Brachytherapy: One or Two Fractions? von Biryukov, Vitaly A., Shchukina, Elizaveta O., Ermakova, Natalia B., Sanin, Dmitry B., Lepilina, Olga G., Karyakin, Oleg B., Ivanov, Sergey A., Kaprin, Andrey D.

Volltext

PPP03 Presentation Time: 10:48 AM von Biryukov, Vitaly A., Makarova, Kseniia S., Troyanov, Alexey V., Gumenetskaya, Yulia V., Rodina, Tatyana A., Shchukina, Elizaveta O., Karyakin, Oleg B., Ivanov, Sergey A., Kaprin, Andrey D.

Volltext

PPP03 Presentation Time: 10:48 AM: Treatment Outcomes of External Beam Radiotherapy, Brachytherapy Boost and Androgen Deprivation Therapy with or without Chemotherapy for Very-High... von Biryukov, Vitaly A., Makarova, Kseniia S., Troyanov, Alexey V., Gumenetskaya, Yulia V., Rodina, Tatyana A., Shchukina, Elizaveta O., Karyakin, Oleg B., Ivanov, Sergey A., Kaprin, Andrey D.

Volltext

Saturday, June 24, 202311:00 AM - 12:00 PMPP01 Presentation Time: 11:00 AM von Biryukov, Vitaly A., Shchukina, Elizaveta O., Ermakova, Natalia B., Lepilina, Olga G., Sanin, Dmitry B., Karyakin, Oleg B., Ivanov, Sergey A., Kaprin, Andrey D.

Volltext

PP04  Presentation Time: 9:47 AM von Biryukov, Vitaly A., Makarova, Kseniia S., Gumenetskaya, Yulia V., Rodina, Tatyana A., Galitsyna, Anastasia B., Shchukina, Elizaveta O., Karyakin, Oleg B., Ivanov, Sergey A., Kaprin, Andrey D.

Volltext

Saturday, June 24, 202311:00 AM - 12:00 PMPP01 Presentation Time: 11:00 AM: High-Dose-Rate Brachytherapy as Monotherapy in the Treatment of Localized Prostate Cancer von Biryukov, Vitaly A., Shchukina, Elizaveta O., Ermakova, Natalia B., Lepilina, Olga G., Sanin, Dmitry B., Karyakin, Oleg B., Ivanov, Sergey A., Kaprin, Andrey D.

Volltext

PP04  Presentation Time: 9:47 AM: Outcomes of Patients with Unfavorable Intermediate Risk Prostate Cancer Treated with External Beam Radiotherapy and Brachytherapy with or without... von Biryukov, Vitaly A., Makarova, Kseniia S., Gumenetskaya, Yulia V., Rodina, Tatyana A., Galitsyna, Anastasia B., Shchukina, Elizaveta O., Karyakin, Oleg B., Ivanov, Sergey A., Kaprin, Andrey D.

Volltext

A Randomized Phase II/III Study of Naptumomab Estafenatox + IFNα versus IFNα in Renal Cell Carcinoma: Final Analysis with Baseline Biomarker Subgroup and Trend Analysis von Hawkins, Robert E, Gore, Martin, Shparyk, Yaroslav, Bondar, Vladimir, Gladkov, Oleg, Ganev, Tosho, Harza, Mihai, Polenkov, Serhii, Bondarenko, Igor, Karlov, Petr, Karyakin, Oleg, Khasanov, Rustem, Hedlund, Gunnar, Forsberg, Goran, Nordle, Örjan, Eisen, Timothy

Volltext

RECORD-4 multicenter phase II trial of second-line everolimus (EVE) in patients (pts) with metastatic renal cell carcinoma (mRCC): Anti-VEGF cohort subanalysis von Cosgriff, Thomas, Yang, Lin, Alyasova, Anna, Ye, Dingwei, Karpenko, Andrey, Li, Hanzhong, Alekseev, Boris, Xie, Li-ping, Kowalyszyn, Ruben Dario, Karyakin, Oleg, Neron, Yeni Verónica, Collins, LaTonya, Brechenmacher, Thomas, Lin, Chinjune, Morgan, Liza, Motzer, Robert J.

Volltext

RECORD-4 phase 2 trial of second-line everolimus (EVE) in patients (pts) with metastatic renal cell carcinoma (mRCC): Final OS analysis von Cosgriff, Thomas, Yang, Lin, Alyasova, Anna, Ye, Dingwei, Karpenko, Andrey, Li, Hanzhong, Alekseev, Boris, Xie, Li-ping, Kowalyszyn, Ruben Dario, Karyakin, Oleg, Neron, Yeni Verónica, Collins, LaTonya, Brechenmacher, Thomas, Lin, Chinjune, Morgan, Liza, Motzer, Robert J.

Volltext

A randomized phase II/III study of naptumomab estafenatox plus IFN-α versus IFN-α in advanced renal cell carcinoma von Hawkins, Robert E., Gore, Martin Eric, Shparyk, Yaroslav, Bondar, Vladimir, Gladkov, Oleg, Ganev, Tosho, Harza, Mihai, Polenkov, Serhii, Bondarenko, Igor, Karlov, Petr A, Karyakin, Oleg, Khasanov, Rustem, Hedlund, Gunnar Eric, Forsberg, Goran, Nordle, Orjan, Eisen, Tim

Volltext

Double-blind randomized trial of aflibercept versus placebo with docetaxel and prednisone for treatment of metastatic castration-resistant prostate cancer (mCRPC) von Tannock, Ian, Fizazi, Karim, Ivanov, Sergey, Thellenberg-Karlsson, Camilla, Flechon, Aude, Skoneczna, Iwona Anna, Orlandi, Francisco Jorquera, Gravis, Gwenaelle, Matveev, Vsevolod, Bavbek, Sevil E., Gil, Thierry, Viana, Luciano S., Aren, Osvaldo, Karyakin, Oleg, Elliott, Tony, Birtle, Alison J., Magherini, Emmanuelle, Petrylak, Daniel Peter, Tombal, Bertrand, Rosenthal, Mark

Volltext

Aflibercept versus placebo in combination with docetaxel/prednisone for first-line treatment of men with metastatic castration-resistant prostate cancer (mCRPC): Results from the m... von Tannock, Ian, Fizazi, Karim, Ivanov, Sergei, Karlsson, Camilla Thellenberg, Flechon, Aude, Skoneczna, Iwona Anna, Orlandi, Francisco Jorquera, Gravis, Gwenaelle, Matveev, Vsevolod B., Bavbek, Sevil E., Gil, Thierry, Viana, Luciano S., Aren, Osvaldo Rudy, Karyakin, Oleg, Elliott, Tony, Birtle, Alison J., Magherini, Emmanuelle, Hatteville, Laurence, Tombal, Bertrand, Rosenthal, Mark

Volltext

Comparison of two doses of cabazitaxel plus prednisone in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) previously treated with a docetaxel (D)-contai... von Eisenberger, Mario A., Hardy-Bessard, Anne-Claire, Mourey, Loic, Mainwaring, Paul N., Ford, Daniel, Shapiro, Jeremy David, Carles, Joan, Ng, Siobhan, Gil, Thierry, Alekseev, Boris, Ivanov, Sergey, Facchini, Thomas, Legouffe, Eric, Apolikhin, Oleg, Pandha, Hardev S., Beeker, Aart, Karyakin, Oleg, Zhang, Wendy, Chadjaa, Mustapha, De Bono, Johann Sebastian

Volltext

METHOD FOR COMPLEX HORMONE-CHEMORADIATION TREATMENT OF LOCALIZED OR LOCALLY ADVANCED PROSTATE CANCER OF HIGH AND VERY HIGH RISK OF PROGRESSING von Gumenetskaya Yuliya Vasilevna, Karyakin Oleg Borisovich, Biryukov Vitalij Aleksandrovich, Troyanov Aleksej Vladimirovich

Volltext bestellen

PICKUP FOR DETERMINATION OF AMMONIA IN GASES von SOBOROVER EDUARD I,SU, PAKHOMOV LEV G,SU, FEL YAKOV A,SU, KARYAKIN OLEG V,SU

Volltext bestellen